2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethylethanamine;2-[(3-butyl-1-isoquinolyl)oxy]-N,N-dimethyl-ethanamine;2-[(3-butyl-1-isoquinolyl)oxy]-N,N-dimethylethanamine;2-[(3-butyl-1-isoquinolyl)oxy]ethyl-dimethyl-amine;2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethyl-ethanamine;BSPBio_000600;Prestwick3_000630;Prestwick0_000630;Prestwick1_000630;BPBio1_000660;CAS-2773-92-4;NCGC00016618-01;1-(.beta.-Dimethylaminoethoxy)-3-N-butylisoquinoline;2-(Dimethylamino)ethoxy-3-butyl-isoquinoline;3-Butyl-1-[2-(dimethylamino)ethoxy]isoquinoline;3-Butyl-1-[2-(dimethylamino)ethyl]isoquinoline;Chinisocain;Dimethisoquin;Ethanamine, 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethyl-;Histaderme;Isochinol;Isoquinoline, 3-butyl-1-[2-(dimethylamino)ethoxy]-;Isoquinoline, 3-butyl-1-[2-(dimethylamino)ethyl]-;Kinisokain;NSC39695;Prulantex;Pruralgan;Pruralgin;Quinisocain;Quinisocaine;Quinoleine;WLN: T66 CNJ BO2N1&1 D4;AO-080/43342670;Prestwick2_000630;ST076784;1-(2-Dimethylaminoethoxy)-3-butylisochinolin;3-Butyl-1-(2-dimethylaminoethoxy)isoquinoline;5-21-03-00414 (Beilstein Handbook Reference);BRN 0018179;Chinisocainum;EINECS 201-700-0;Ethanamine, 2-((3-butyl-1-isoquinolinyl)oxy)-N,N-dimethyl-;ISOQUINOLINE, 3-BUTYL-1-(2-(DIMETHYLAMINO)ETHOXY)-;Quinisocaina [INN-Spanish];Quinisocainum [INN-Latin];SPBio_002819
2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethylethanamine